Clinical Trials Browser

Phase 2 × Completed × Neoplasms, Unknown Primary × Clear all

NCT05024968 2026-02-25

Sintilimab in Cancer of Unknown Primary

Phase 2 Completed

10 enrolled 9 charts

Neoplasms, Unknown Primary

NCT03752333 2026-01-22

CUPem

Phase 2 Completed

Neoplasms, Unknown Primary

NCT03498521 2025-11-19

CUPISCO

Phase 2 Completed

529 enrolled 16 charts

Neoplasms, Unknown Primary

NCT02607202 2024-01-26

AGNOSTOS

Phase 2 Completed

Neoplasms, Unknown Primary

NCT01845337 2023-05-12

TOFFEE

Phase 2 Completed

Gastrointestinal

Bile Duct Neoplasms, Gastrointestinal Neoplasms, Neoplasms, Unknown Primary, Pancreatic Neoplasms

NCT00357630 2020-11-02

Gemcitabine in Treating Patients With Metastatic Cancer of Unknown Primary

Phase 2 Completed

Neoplasms, Unknown Primary, Pain

NCT00004005 2017-04-26

Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin

Phase 2 Completed

Gastrointestinal

Colonic Neoplasms, Neoplasms, Unknown Primary, Rectal Neoplasms, Colorectal Neoplasms

NCT00066781 2017-04-04

Gemcitabine and Irinotecan in Treating Patients With Cancer of Unknown Primary

Phase 2 Completed

31 enrolled 8 charts

Neoplasms, Unknown Primary

NCT00936702 2017-03-21

Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary

Phase 2 Completed

46 enrolled 13 charts

Neoplasms, Unknown Primary

NCT00003657 2017-01-20

High-dose ICE With Amifostine

Phase 2 Completed

CNSGenitourinaryGynecologicHead & NeckSarcomaThoracic

AIDS-related Kaposi sarcoma, Testicular Germ Cell Tumor, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Chondrosarcoma, Head and Neck Neoplasms, Kidney Neoplasms, Lung Neoplasms, Neoplasms, Unknown Primary, Ovarian Neoplasms, Sarcoma, Sarcoma, Kaposi, Osteosarcoma, Testicular Neoplasms, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral, Esthesioneuroblastoma, Olfactory, Small Cell Lung Carcinoma

NCT00873119 2015-07-28

Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown Primary

Phase 2 Completed

89 enrolled 12 charts

Neoplasms, Unknown Primary

NCT00360360 2013-12-04

Paclitaxel/Carboplatin Plus Bevacizumab/Erlotinib in the First Line Treatment of Carcinoma of Unknown Primary Site

Phase 2 Completed

60 enrolled 6 charts

Neoplasms, Unknown Primary

NCT00193609 2013-11-11

Oxaliplatin and Capecitabine in the Treatment of Relapsed/Refractory Carcinoma of Unknown Primary Site

Phase 2 Completed

48 enrolled 6 charts

Neoplasms, Unknown Primary

NCT00004922 2013-06-19

Irinotecan in Treating Patients With Advanced Neuroendocrine Tumors

Phase 2 Completed

DermatologicEndocrine

Neoplasms, Unknown Primary, Carcinoma, Merkel Cell, Carcinoma, Neuroendocrine

NCT00003943 2013-04-17

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer.

Phase 2 Completed

Lung Neoplasms, Neoplasms, Unknown Primary

NCT00353145 2012-08-02

Gemox as First and Second Line Therapy in Unknown Primary Cancer

Phase 2 Completed

Neoplasms, Unknown Primary

NCT00193622 2010-09-17

Bevacizumab and Erlotinib in the Treatment of Patients With Carcinoma of Unknown Primary Site

Phase 2 Completed

Neoplasms, Unknown Primary

NCT00006361 2009-12-04

SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck

Phase 2 Completed

DermatologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Nasopharyngeal Neoplasms, Neoplasms, Unknown Primary, Skin Neoplasms